Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $26.1 million versus the consensus estimate of $23.55 million.

For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.